(Adds trial and disease details in paragraphs 2 to 4) Sept 24 (Reuters) – Merck said on Thursday its drug met the main goal in a mid- to late-stage trial testing it in adult patients with a type of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)